Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 21

Sort by

Sort Order Select

Journal Articles

Diarrheal Morbidity in Patients Undergoing Hematopoietic Cell Transplantation - the Diagnostic Yield of Stool Cultures

Tamar Berger, MD, Odil Giladi, MD, Dafna Yahav, MD, Haim Ben-Zvi, Oren Pasvolsky, MD, Liat Shargian-Alon, MD, Ofir Wolach, MD, Uri Rozovski, MD, Pia Raanani, MD, Moshe Yeshurun, MD

Blood (2020) 136 (Supplement 1): 26–27.

https://doi.org/10.1182/blood-2020-138630

Published: 2020

Journal Articles

Venetoclax and DLI for Patients with Early Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. a Historical Prospective Multicenter Trial

Odelia Amit, MD, Yael Bar-On, MD, Galit Perets, MD, Lena Atlas, Liat Shargian, MD, Moshe Yeshurun, MD, Bruria Yachini, RN, Chen Karni, RN, Ron Ram, MD

Blood (2019) 134 (Supplement_1): 2018.

https://doi.org/10.1182/blood-2019-126999

Published: 2019

Journal Articles

Is the Achievement of Pre-Autologous Transplant CR Necessary Indeed in Refractory/ Relapsed DLBCL Patients? a Retrospective Multicenter Study

Liat Shargian-Alon, MD, Hanna Bernstine, Galit Perets, MD, Ronit Gurion, Anat Gafter-Gvili, MD, Oren Pasvolsky, MD, Michal Navon Sela, Chava Perry, MD PhD, Irit Avivi, MD, Odelia Amit, MD, Pia Raanani, MD, Ron Ram, MD, Moshe Yeshurun, MD

Blood (2019) 134 (Supplement_1): 5703.

https://doi.org/10.1182/blood-2019-131229

Published: 2019

Journal Articles

Efficacy and Safety of Autologus Hematopoietic Cell Transplantation in Elderly Patients with Multiple Myeloma: A Retrospective Israeli Multi-Site Cohort Study

Yael C Cohen, MD, Tsila Zuckerman, MD, Moshe Yeshurun, MD, Galit Perez, MD, Hila Magen, MD, Israel Henig, MD, Itai Levi, MD, Liat Shargian, Svetlana Trestman, MD, Uri Rouvio, MD, Elizabeth Naparstek, MD, Eti Ganon-Elazar, PhD, Irit Avivi, MD, Ron Ram, MD

Blood (2014) 124 (21): 3989.

https://doi.org/10.1182/blood.V124.21.3989.3989

Published: 2014

Journal Articles

Low Vs. High Intensity BEAM Prior To Autologous Hematopoietic Cell Transplantation For Chemosensitive Lymphoma Patients - A Matched Cohort Analysis

Galit Perez Avraham, MD, Moshe Yeshurun, MD, Itai Levi, MD, Corina Hershcovici, MD, Ory Rouvio, MD, PhD, Oleg Pikovsky, MD, Ofer Shpilberg, M.D, M.P.H, Ron Ram, MD

Blood (2013) 122 (21): 3391.

https://doi.org/10.1182/blood.V122.21.3391.3391

Published: 2013

Journal Articles

Cannabidiol - An Innovative Strategy For Graft Versus Host Disease Prevention

Moshe Yeshurun, MD, Ofer Shpilberg, MD, MPH, Corina Herscovici, MD, Juliet Dreyer, RN, Anat Peck, RN, Maly Levy Assaraf, PhD, Tsipora Gruenewald, M.Ph.Sc, Raphael Mechoulam, PhD, Ron Ram, MD

Blood (2013) 122 (21): 3299.

https://doi.org/10.1182/blood.V122.21.3299.3299

Published: 2013

Journal Articles

Secondary Malignancies Following High Dose Therapy and Autologous Hematopoietic Cell Transplantation - Systematic Review and Meta Analysis

Iuliana Vaxman, M.D., Ron Ram, MD, Anat Gafter-Gvili, MD, Liat Vidal, MD MSc, Moshe Yeshurun, MD, Meir Lahav, MD, Ofer Shpilberg, MD, MPH

Blood (2013) 122 (21): 4633.

https://doi.org/10.1182/blood.V122.21.4633.4633

Published: 2013

Journal Articles

Elevation of CRP Precedes Bloodstream Infections in Patients Undergoing Hematopoietic Cell Transplantation – a Case-Control Study.

Ron Ram, M.D, Moshe Yeshurun, MD, Laura Farber, Leonard Leibovici, MD, Corina Herscovici, MD, Ofer Shpilberg, MD, MPH, Mical Paul, MD

Blood (2012) 120 (21): 3026.

https://doi.org/10.1182/blood.V120.21.3026.3026

Published: 2012

Journal Articles

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT.

Moshe Yeshurun, MD, Myriam Labopin, Didier Blaise, MD, Jan Cornelissen, MD PhD, Henrik Sengeloev, MD, PhD, Lars Vindelov, MD, Jurgen H Kuball, MD, PhD, Patrice Chevallier, MD, PhD, Arnon Nagler, MD, Mohamad Mohty, MD PhD

Blood (2012) 120 (21): 3098.

https://doi.org/10.1182/blood.V120.21.3098.3098

Published: 2012

Journal Articles

Mycophenolate Mofetil Vs. Methotrexate for the Prophylaxis of Graft-Versus-Host-Disease - Systematic Review and Meta-Analysis of All Comparative Trials

Ron Ram, M.D, Moshe Yeshurun, MD, Liat Vidal, MD, Ofer Shpilberg, M.D, M.P.H, Anat Gafter-Gvili, M.D

Blood (2012) 120 (21): 4169.

https://doi.org/10.1182/blood.V120.21.4169.4169

Published: 2012

Journal Articles

Female Donor Allografts Have a Higher CD3 Content Than Male Donor Allografts: Potential Impact On Transplantation Outcomes in Male Recipients

Moshe Yeshurun, MD, Ron Ram, MD, Ofer Shpilberg, MD, MPH, Corina Herscovici, MD, Liat Vidal, MD, Tsila Zuckerman, MD, Nuhad Haddad, MD, Jacob M Rowe, MD, Ronit Yerushalmi, Arnon Nagler, MD, Avichai Shimoni

Blood (2012) 120 (21): 587.

https://doi.org/10.1182/blood.V120.21.587.587

Published: 2012

Journal Articles

The Role of PET-CT for the Diagnosis of Infections in Hemato-Oncological Patients with Persistent Febrile Neutropenia

Anat Gafter-Gvili, MD, Mical Paul, MD, Hanna Bernstine, MD, Liat Vidal, MD, Ron Ram, MD, Pia Raanani, MD, Moshe Yeshurun, MD, Boaz Tadmor, MD, Ofer Shpilberg, MD, MPH, David Groshar, MD

Blood (2011) 118 (21): 4289.

https://doi.org/10.1182/blood.V118.21.4289.4289

Published: 2011

Journal Articles

Hematopoietic Growth Factors In Aplastic Anemia Patients Treated with Immunosuppressive Therapy: Systematic Review and Meta-Analysis - 2010 Update.

Ronit Gurion, Anat Gafter-Gvili, MD, Liat Vidal, Mical Paul, Isaac Ben-Bassat, MD, Moshe Yeshurun, MD, Ofer Shpilberg, MD, MPH, Pia Raanani, MD

Blood (2010) 116 (21): 1164.

https://doi.org/10.1182/blood.V116.21.1164.1164

Published: 2010

Journal Articles

A Multi-Center Prospective Randomized Study Comparing Ibritumomab Tiuxetan (Zevalin) and High-Dose BEAM Chemotherapy (Z-BEAM) Vs. BEAM Alone as the Conditioning Regimen Prior to Autologous Stem-Cell Transplantation In Patients with Aggressive Lymphoma; Possible Advantage for Z-BEAM In Low-Risk Patients

Avichai Shimoni, MD, Irit Avivi, MD, Jacob M. Rowe, Moshe Yeshurun, MD, Itai Levi, MD, Reuven Or, MD, Paulina Patachenko, MD, Abraham Avigdor, MD, Tzila Zwas, MD, Arnon Nagler, M.D.

Blood (2010) 116 (21): 686.

https://doi.org/10.1182/blood.V116.21.686.686

Published: 2010

Journal Articles

Treatment of Severe Acute Graft-Versus-Host Disease with Mesenchymal Stromal Cells.

Igor B Resnick, Jr., MD, PhD, DSci, Polina Stepensky, MD, Michael Y. Shapira, MD, Claudine Barkatz, MSc, Gregory Elkin, PhD, Olga Gurevich, PhD, Avichai Shimoni, MD, Nira Varda-Bloom, PhD, Moshe Yeshurun, MD, Amos Toren, Sr., MD, PhD, Tsila Zukerman, MD, Michael Weintraub, Sr., MD, Arnon Nagler, MD, Reuven Or, MD

Blood (2009) 114 (22): 2249.

https://doi.org/10.1182/blood.V114.22.2249.2249

Published: 2009

Journal Articles

ATG Plus Cyclosporine-a Should Be Used as Immunosuppressive Therapy in Patients with Severe Aplastic Anemia-Systematic Review and Meta-Analysis

Anat Gafter-Gvili, MD, Ron Ram, MD, Ronit Gurion, MD, Mical Paul, MD, Moshe Yeshurun, MD, Pia Raanani, MD, Ofer Shpilberg, MD

Blood (2008) 112 (11): 4120.

https://doi.org/10.1182/blood.V112.11.4120.4120

Published: 2008

Journal Articles

Prolongation of Post Relapse and Overall Survival in Patients with Multiple Myeloma by Salvage Strategy with the Combination of Thalidomide and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation Based on the Nature of Disease Progression after Autologous Bone Marrow Transplantation.

Izhar Hardan, MD, Avichai Shimoni, MD, Abraham Kneller, MD, Abraham Avigdor, MD, Noga Shemtov, MD, Miriam Berkowicz, MD, Yaron Davidowitz, MD, Moshe Yeshurun, MD, Ronit Yerushalmi, MD, Leiba Meirav, MD, Bar-Nathan Michal, MD, Ben-Bassat Izaac, MD, Nagler Arnon, MD

Blood (2005) 106 (11): 3494.

https://doi.org/10.1182/blood.V106.11.3494.3494

Published: 2005

Journal Articles

Allogeneic Hematopoietic Stem-Cell Transplantation in AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: The Role of Dose-Intensity.

Avichai Shimoni, MD, Izhar Hardan, MD, Noga Shem-Tov, MD, Moshe Yeshurun, MD, Ronit Yerushalmi, MD, Isaac Ben-Bassat, MD, Arnon Nagler, MD

Blood (2005) 106 (11): 47.

https://doi.org/10.1182/blood.V106.11.47.47

Published: 2005

Journal Articles

Allogeneic Stem-Cell Transplantation in Patients with AML and MDS Using Myeloablative Versus Reduced-Intensity Doses of Intravenous Busulfan : The Role of Dose Intensity.

Avichai Shimoni, MD, Moshe Yeshurun, MD, Izhar Hardan, MD, Abraham Avigdor, MD, Noga Shem-Tov, MD, Isaac Ben-Bassat, MD, Arnon Nagler, MD

Blood (2004) 104 (11): 2308.

https://doi.org/10.1182/blood.V104.11.2308.2308

Published: 2004

Journal Articles

Hematopoietic Stem-Cell Transplantation from Unrelated Donors in Elderly Patients (> 55 Years): Older Age Is No Longer a Contraindication When Using Reduced Intensity Conditioning.

Avichai Shimoni, MD, Nicolaus Kröger, MD, Tatjana Zabelina, MD, Frances Ayuk, MD, Izhar Hardan, MD, Moshe Yeshurun, MD, Noga Shem-Tov, MD, Abraham Avigdor, MD, Isacc Ben-Bassat, MD, Axel Zander, MD, Arnon Nagler, MD

Blood (2004) 104 (11): 2750.

https://doi.org/10.1182/blood.V104.11.2750.2750

Published: 2004

NARROW

Diarrheal Morbidity in Patients Undergoing Hematopoietic Cell Transplantation - the Diagnostic Yield of Stool Cultures

Venetoclax and DLI for Patients with Early Relapse of Acute Myeloid Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation. a Historical Prospective Multicenter Trial

Is the Achievement of Pre-Autologous Transplant CR Necessary Indeed in Refractory/ Relapsed DLBCL Patients? a Retrospective Multicenter Study

Efficacy and Safety of Autologus Hematopoietic Cell Transplantation in Elderly Patients with Multiple Myeloma: A Retrospective Israeli Multi-Site Cohort Study

Low Vs. High Intensity BEAM Prior To Autologous Hematopoietic Cell Transplantation For Chemosensitive Lymphoma Patients - A Matched Cohort Analysis

Cannabidiol - An Innovative Strategy For Graft Versus Host Disease Prevention

Secondary Malignancies Following High Dose Therapy and Autologous Hematopoietic Cell Transplantation - Systematic Review and Meta Analysis

Elevation of CRP Precedes Bloodstream Infections in Patients Undergoing Hematopoietic Cell Transplantation – a Case-Control Study.

Impact of Postremission Consolidation Chemotherapy On Outcome After Reduced-Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (allo-SCT) for AML in First Complete Remission (CR1): A Report From the Acute Leukemia Working Party of EBMT.

Mycophenolate Mofetil Vs. Methotrexate for the Prophylaxis of Graft-Versus-Host-Disease - Systematic Review and Meta-Analysis of All Comparative Trials

Female Donor Allografts Have a Higher CD3 Content Than Male Donor Allografts: Potential Impact On Transplantation Outcomes in Male Recipients

The Role of PET-CT for the Diagnosis of Infections in Hemato-Oncological Patients with Persistent Febrile Neutropenia

Hematopoietic Growth Factors In Aplastic Anemia Patients Treated with Immunosuppressive Therapy: Systematic Review and Meta-Analysis - 2010 Update.

Treatment of Severe Acute Graft-Versus-Host Disease with Mesenchymal Stromal Cells.

ATG Plus Cyclosporine-a Should Be Used as Immunosuppressive Therapy in Patients with Severe Aplastic Anemia-Systematic Review and Meta-Analysis

Prolongation of Post Relapse and Overall Survival in Patients with Multiple Myeloma by Salvage Strategy with the Combination of Thalidomide and Reduced Intensity Conditioning Allogeneic Stem Cell Transplantation Based on the Nature of Disease Progression after Autologous Bone Marrow Transplantation.

Allogeneic Hematopoietic Stem-Cell Transplantation in AML and MDS Using Myeloablative Versus Reduced Intensity Conditioning: The Role of Dose-Intensity.

Allogeneic Stem-Cell Transplantation in Patients with AML and MDS Using Myeloablative Versus Reduced-Intensity Doses of Intravenous Busulfan : The Role of Dose Intensity.

Hematopoietic Stem-Cell Transplantation from Unrelated Donors in Elderly Patients (> 55 Years): Older Age Is No Longer a Contraindication When Using Reduced Intensity Conditioning.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only